Parkinson's disease (PD) is a chronic, progressive neurological disorder characterized by motor and non-motor symptoms. The disease is primarily associated with the degeneration of dopaminergic neurons in the substantia nigra, leading to various clinical manifestations.
PD is characterized by the loss of dopamine-producing cells in the substantia nigra, a region of the midbrain. This loss leads to an imbalance in the basal ganglia's neuronal activity, resulting in the cardinal motor symptoms of PD: bradykinesia, rigidity, and tremor. The exact cause of neuronal death remains unknown, but a combination of genetic and environmental factors is believed to contribute.
PD typically presents with motor symptoms such as resting tremor, bradykinesia, rigidity, and postural instability. However, non-motor symptoms like autonomic dysfunction, cognitive impairment, mood disorders, and sleep disturbances often precede motor symptoms and contribute significantly to patient disability.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and the exclusion of other conditions. Currently, there are no definitive diagnostic tests for PD. Neuroimaging techniques, such as DaTSCAN, can support the diagnosis but are not routinely used due to their high cost and limited availability.
The mainstay of PD treatment is pharmacological therapy aimed at restoring dopamine levels in the brain. Levodopa, often combined with carbidopa, is the most effective treatment. Other drugs, such as dopamine agonists and MAO-B inhibitors, are also used. Non-pharmacological treatments, including physiotherapy and deep brain stimulation, may be beneficial in managing specific symptoms.
PD is a complex disorder with a multifaceted clinical presentation. Understanding its pathophysiology, clinical manifestations, and treatment options is essential for healthcare professionals to provide optimal patient care. Ongoing research aims to uncover the underlying mechanisms of PD and develop novel therapeutic strategies.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation